The Pharmaceutical Committee seeks equitable rewards for innovation on the research and development investment of European firms and partnership with the Taiwan Government on fostering Taiwan's biotech and R&D development. Key
issues include Taiwan's manufacturing validation, sustainability of the healthcare system, drug pricing policy and IPR issues including data exclusivity and counterfeit drugs.
Committee Dedicated Staff
||Mr. Rene Jensen
Vice President & General Manager
GSK Taiwan Ltd.
||Ms. Linda Sheng
Hoan Pharmaceuticals Ltd.
||Mr. Mike Exton
Novartis (Taiwan) Co.Ltd.
Cosmetics, Medical Device, Pharmaceutical, Healthcare Enhancement
Tel: 886-2-2740-0236 ext 228